The Signature of Serum Modified Nucleosides in Uveitis
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.2.68 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Haoze Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Uveitis, Nucleosides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Eye Center, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
- Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Institute of Genetics, Zhejiang University International School of Medicine, Hangzhou, China.
Zitieren
APA
Zhou, H., Hu, Y., Qin, G., Kong, J., Hong, X., Guo, C., Zou, J., & Feng, L. (2025). The Signature of Serum Modified Nucleosides in Uveitis. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.68
Vancouver
Zhou H, Hu Y, Qin G, Kong J, Hong X, Guo C, et al. The Signature of Serum Modified Nucleosides in Uveitis. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.68
BibTeX
@article{Zhou2025,
author = {Zhou, Haoze and Hu, Yiqiu and Qin, Guangming and Kong, Jinfeng and Hong, Xiujuan and Guo, Cheng and Zou, Jian and Feng, Lei},
title = {The Signature of Serum Modified Nucleosides in Uveitis},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.2.68}
}
EUVIMED